Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03675308 |
|---|---|
| Brief Title: | A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1) |
| First Submitted : | September 12, 2018 |
| First Submitted that Met QC Criteria : | September 15, 2018 |
| First Posted : | September 18, 2018 |
| Results First Submitted : | January 24, 2022 |
| Results First Posted with QC Comments : | February 16, 2022 |
| Results First Submitted that Met QC Criteria : | February 23, 2022 |
| Results First Posted : | February 24, 2022 |
| Certification/Extension First Submitted : | September 21, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | February 23, 2022 |
| Certification/Extension First Posted : | February 24, 2022 |
| Last Update Submitted that Met QC Criteria : | February 23, 2022 |
| Last Update Posted : | February 24, 2022 |